Study of CAbozantinib in Combination With AtezolizumaB for Muscle-Invasive BladdEr Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Bladder Cancer
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04289779
- Collaborators
- Exelixis
- Genentech, Inc.
- Medical College of Wisconsin
- Investigators
- Principal Investigator: Deepak Kilari, MD Medical College of Wisconsin
Get Well Soon